Published in Eukaryot Cell on October 01, 2004
Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell (2008) 2.71
Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog (2010) 2.28
Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun (2008) 2.15
Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis (2010) 1.96
Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot Cell (2005) 1.89
A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. Cell Host Microbe (2011) 1.80
Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun (2009) 1.66
Cryptococcal interactions with the host immune system. Eukaryot Cell (2010) 1.57
Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun (2007) 1.55
How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol (2009) 1.43
Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect Immun (2010) 1.40
Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell (2007) 1.39
Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH. MBio (2011) 1.15
Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidification. Proc Natl Acad Sci U S A (2006) 1.10
Titan cell production enhances the virulence of Cryptococcus neoformans. Infect Immun (2012) 1.07
Coevolution of morphology and virulence in Candida species. Eukaryot Cell (2011) 1.07
Global transcriptome profile of Cryptococcus neoformans during exposure to hydrogen peroxide induced oxidative stress. PLoS One (2013) 1.00
Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS One (2010) 0.97
Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast (2014) 0.94
Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell (2014) 0.93
Candida albicans: A Model Organism for Studying Fungal Pathogens. ISRN Microbiol (2012) 0.91
Cryptococcus neoformans induces IL-8 secretion and CXCL1 expression by human bronchial epithelial cells. Respir Res (2008) 0.91
Atf2 transcription factor binds to the APP1 promoter in Cryptococcus neoformans: stimulatory effect of diacylglycerol. Eukaryot Cell (2007) 0.88
Applying genetics and molecular biology to the study of the human pathogen Cryptococcus neoformans. Methods Enzymol (2010) 0.87
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. PLoS Pathog (2015) 0.87
Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative Model. Front Microbiol (2016) 0.87
Host immunity to Cryptococcus neoformans. Future Microbiol (2015) 0.85
Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors. J Immunol (2009) 0.85
Coccidioides Endospores and Spherules Draw Strong Chemotactic, Adhesive, and Phagocytic Responses by Individual Human Neutrophils. PLoS One (2015) 0.84
Morphology and its underlying genetic regulation impact the interaction between Cryptococcus neoformans and its hosts. Med Mycol (2015) 0.83
Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis. Cell Microbiol (2006) 0.83
A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic Outcome. PLoS Pathog (2015) 0.81
A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One (2011) 0.81
Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis. Fungal Genet Biol (2013) 0.79
Cryptococcus inositol utilization modulates the host protective immune response during brain infection. Cell Commun Signal (2014) 0.78
Approaching the functional annotation of fungal virulence factors using cross-species genetic interaction profiling. PLoS Genet (2012) 0.77
Temporal behavior of capsule enlargement by Cryptococcus neoformans. Eukaryot Cell (2013) 0.77
Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans. Front Microbiol (2016) 0.75
Networks of fibers and factors: regulation of capsule formation in Cryptococcus neoformans. F1000Res (2016) 0.75
Diagnostic Challenges of Cryptococcus neoformans in an Immunocompetent Individual Masquerading as Chronic Hydrocephalus. Case Rep Neurol Med (2016) 0.75
Elucidation of the Role of 3-Hydroxy Fatty Acids in Cryptococcus-amoeba Interactions. Front Microbiol (2017) 0.75
Nonfilamentous C. albicans mutants are avirulent. Cell (1997) 13.83
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide. Infect Immun (1971) 5.45
Putative virulence factors of Candida albicans. Annu Rev Microbiol (1991) 4.85
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis (2002) 4.56
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis (1972) 3.75
Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun (2000) 3.42
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A (2001) 3.37
Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect Immun (1997) 3.14
Cryptococcus neoformans. II. Phagocytosis by human leukocytes. J Bacteriol (1967) 3.09
Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun (1984) 3.07
Fungal morphogenesis and host invasion. Curr Opin Microbiol (2002) 3.01
Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med (2000) 2.99
Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol (1999) 2.78
A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell (2003) 2.59
Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol (2002) 2.35
Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect Immun (1984) 2.30
Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol (1997) 2.25
Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis (2002) 2.20
Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun (1988) 2.05
Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis (1988) 2.03
Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect Immun (1988) 1.94
Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila. Infect Immun (1999) 1.93
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun (2003) 1.89
How does Cryptococcus get its coat? Trends Microbiol (2000) 1.86
The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect (2003) 1.84
CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity (2002) 1.83
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun (1991) 1.80
'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm. Curr Opin Microbiol (2003) 1.79
CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med (1992) 1.79
Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect Immun (1989) 1.76
Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev (2001) 1.72
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun (1995) 1.70
Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol (1989) 1.69
Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest (2003) 1.66
Molecular architecture of the Cryptococcus neoformans capsule. Mol Microbiol (2004) 1.66
Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect Immun (1998) 1.63
Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect Immun (1990) 1.62
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol (2001) 1.48
The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol (2003) 1.45
Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol Microbiol (2002) 1.45
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood (2003) 1.45
Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun (2003) 1.44
Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun (1997) 1.41
Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest (2001) 1.38
Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol (1994) 1.37
Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun (2002) 1.31
Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol (1989) 1.31
Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect Immun (2004) 1.31
Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun (1995) 1.31
Mechanisms of bacterial pathogenicity. Postgrad Med J (2002) 1.29
The role of Legionella pneumophila-infected Hartmannella vermiformis as an infectious particle in a murine model of Legionnaire's disease. Infect Immun (1997) 1.27
Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol (2000) 1.25
Interactions of fungi with phagocytes. Curr Opin Microbiol (2002) 1.24
Advantage of Fontana-Masson stain in capsule-deficient cryptococcal infection. Arch Pathol Lab Med (1987) 1.23
Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett (2000) 1.23
Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. Am Rev Respir Dis (1987) 1.20
Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun (1988) 1.19
The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J Leukoc Biol (2003) 1.17
Antifungal activity of a human antiglucuronoxylomannan antibody. Clin Diagn Lab Immunol (1998) 1.16
Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity. Infect Immun (2002) 1.16
Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol (2000) 1.16
Toll-like receptors and innate antifungal responses. Trends Microbiol (2004) 1.14
Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. J Clin Microbiol (1991) 1.14
Killing of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol (1989) 1.14
Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun (2003) 1.14
Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis (2000) 1.13
Cryptococcus neoformans: virulence and host defences. Med Mycol (1998) 1.12
Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol (2003) 1.10
Phenotypic switching and mating type switching of Candida glabrata at sites of colonization. Infect Immun (2003) 1.09
The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int Immunol (2004) 1.09
The WH11 gene of Candida albicans is regulated in two distinct developmental programs through the same transcription activation sequences. J Bacteriol (1997) 1.09
Candida albicans--do mycelia matter? J Med Vet Mycol (1990) 1.08
Phenotypic consequences of red-white colony type variation in Mycobacterium avium. Microbiology (2001) 1.02
Fine structural investigation of Malassezia furfur. II. The envelope of the yeast cells. Mycoses (1995) 1.01
High-frequency switching in Candida albicans and its relations to vaginal candidiasis. Am J Obstet Gynecol (1988) 0.99
Phenotypic switching in Mycoplasma gallisepticum hemadsorption is governed by a high-frequency, reversible point mutation. Infect Immun (2003) 0.99
Phenotypic switching in Cryptococcus neoformans. Microbes Infect (2002) 0.97
Optimization of exopolysaccharide production by Tremella mesenterica NRRL Y-6158 through implementation of fed-batch fermentation. J Ind Microbiol Biotechnol (2002) 0.95
Virulence factors in fungi of systemic mycoses. Rev Inst Med Trop Sao Paulo (1999) 0.93
Immunohistochemical identification of Trichosporon beigelii in histologic section by immunoperoxidase method. Am J Clin Pathol (1988) 0.92
Rhinosporodiosis. Diagnosis by scrape cytology. Acta Cytol (1995) 0.90
Virus phenotype switching and disease progression in HIV-1 infection. Proc Biol Sci (1999) 0.90
Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo (2004) 0.89
Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro. Am J Respir Cell Mol Biol (1996) 0.88
Exopolysaccharides and capsules in human pathogenic Exophiala species. Mycoses (2002) 0.85
Phenotypic and functional characterization of normal rat pleural macrophages in comparison with autologous peritoneal and alveolar macrophages. Am J Respir Cell Mol Biol (1999) 0.85
Pulmonary infection with capsule-deficient cryptococcus neoformans. Virchows Arch A Pathol Anat Histol (1979) 0.84
Cell-wall composition and structure of yeast cells and conjugation tubes of Tremella mesenterica. J Gen Microbiol (1976) 0.83
Lymphocyte adhesion to Candida albicans. Infect Immun (2002) 0.82
Phenotypic switching and genetic diversity of Cryptococcus neoformans. J Clin Microbiol (2001) 0.82
Antigenic variation in Trypanosoma brucei infections: an holistic view. J Cell Sci (1999) 0.82
Lymphonodular cryptococcosis diagnosed by fine needle aspiration cytology in hyper-IgM syndrome. A case report. Acta Cytol (2001) 0.81
Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome? Infect Immun (2000) 0.81
Susceptibility of congenitally immunodeficient mice to a nonencapsulated strain of Cryptococcus neoformans. Can J Microbiol (1991) 0.81
Are two Cryptococcus neoformans strains epidemiologically linked? J Clin Microbiol (2001) 0.81
The "capsule" of Sporotrichum schenckii and the evolution of the asteroid body. A light and electron microscopic study. Sabouraudia (1969) 0.80